Stocks and Investing
Stocks and Investing
Thu, July 22, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, July 21, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Burns Maintained (SWTX) at Strong Buy with Increased Target to $136 on, Jul 21st, 2021
Robert Burns of HC Wainwright & Co., Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Strong Buy with Increased Target from $124 to $136 on, Jul 21st, 2021.
Robert has made no other calls on SWTX in the last 4 months.
There is 1 other peer that has a rating on SWTX. Out of the 1 peers that are also analyzing SWTX, 0 agree with Robert's Rating of Hold.
This is the rating of the analyst that currently disagrees with Robert
- Paul Choi of "Goldman Sachs" Initiated at Strong Buy and Held Target at $112 on, Monday, March 22nd, 2021
Contributing Sources